ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics

Geng, Xue; Chi, Wencheng; Lin, Xiaoyue; Niu, Zeji; Jiang, Qinghui; Sui, Yutong; Jiang, Jiakang*南方医科大学; 1; jk
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries2023-3-31DOI: 10.1097/MD.0000000000033384
17阅读
引用收藏
分享

摘要

Background:Lung adenocarcinoma (LUAD) is the main pathological type of lung cancer. Qishan formula (QSF) is reportedly efficacious against LUAD. However, its mechanisms of action currently remain elusive. Therefore, network pharmacology, molecular docking techniques and proteomics were used to verify the potential pharmacological effects of QSF in the treatment of LUAD. Methods:The active ingredients and potential targets of QSF were obtained from the TCMSP, chemical source network and construct a drug-component-target networks using Cytoscape v3.7.2. Data for disease targets were obtained from 5 databases: TCGA, OMIM, DrugBank, DisGeNET, and GeneCards. Drug disease cross targets were used to construct protein-protein interaction networks for selecting the core targets using the STRING database and enrichment pathway networks using the DAVID database. Finally, TMT quantitative proteomics was used to identify the possible core targets and action pathways. Molecular docking to verify the affinity between components and targets. Results:Network pharmacology identified core components of QSF against LUAD included baicalein, methylophiopogonone B, quercetin, kaempferol, isorhamnetin, and luteolin, which can act on 10 key targets (SRC, TP53, PIK3R1, MAPK3, STAT3, MAKP1, HSP90AA1, PIK3CA, HRAS, and AKT1). QSF might play a therapeutic role in LUAD by regulating biological processes such as signal transduction, protein phosphorylation, cell proliferation, and apoptosis, as well as the PI3K/AKT, MAPK, FoxO, and other signaling pathways. Proteomics identified 207 differentially expressed proteins, and by integrating with network pharmacology and molecular docking results we found that 6 core components of QSF may target TP53 against LUAD through the PI3K/AKT signaling pathway. Conclusion:QSF is a multitarget recipe potentially exerting pleiotropic effects in LUAD.

学科与关键词

关键词
lung adenocarcinomamechanismmolecular dockingnetwork pharmacologyproteomicsQishan formula
相关
加载中…
  • Uncovering the Q-marker and potential mechanisms of Qishan Formula for lung cancer based on multi-technology
    Sui, Yutong*; Yang, Yanqun; Zhang, Jing; Wang, Ziwei; Geng, Xue; Jiang, JiakangJournal of Liquid Chromatography and Related Technologies, 2023, 46(6-10): 118-126.
  • A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification
    Hu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei*; Lin, Lizhu*Evidence-based Complementary and Alternative Medicine, 2023, 2023: 3436814.被引 1
  • Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer
    Cai, Jieqi; Chen, Yupeng; Wang, Kexin; Li, Yi; Wu, Jie; Yu, Hailang; Li, Qingping; Wu, Qi; Meng, Wei; Wang, Handuo; Lu, Aiping; Huang, Mianbo*; Wei, Genxia*; Guan, Daogang*BMC Complementary Medicine and Therapies, 2023, 23(1): 158.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries
发表日期
2023-03-31
卷期
第 102 卷, 第 13 期
DOI
10.1097/MD.0000000000033384
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82104585]; General Project of Heilongjiang Natural Science Foundation [H201478]; Project of Heilongjiang Administration of Traditional Chinese Medicine [ZHY16-120]

作者

  • G

    Geng, Xue (第一作者)

    heilongjiang univ chinese med

  • C

    Chi, Wencheng

    heilongjiang univ chinese med · 1

查看全部 7 位作者收起作者
  • L

    Lin, Xiaoyue

    heilongjiang univ chinese med

  • N

    Niu, Zeji

    heilongjiang univ chinese med

  • J

    Jiang, Qinghui

    1 · heilongjiang univ chinese med

  • S

    Sui, Yutong

    southern med univ

  • J

    Jiang, Jiakang (通讯)

    heilongjiang univ chinese med · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417